Topic

rinvoq

4 articles

EDE approves once-daily Rinvoq for UAE vitiligo patients aged 12+

The UAE is the first market to approve oral Rinvoq for non-segmental vitiligo. Clinics and insurers now face pricing, eligibility and monitoring questions.

23 Aug 2026 · 3 min read

EDE approves once-daily Rinvoq for UAE vitiligo patients aged 12+

EDE approves Rinvoq for vitiligo patients aged 12+ as UAE clinics face AED 5,789 monthly drug cost

The UAE approved once-daily Rinvoq for non-segmental vitiligo. Clinics, insurers and patients now face eligibility, monitoring and coverage decisions.

21 Aug 2026 · 3 min read

EDE approves Rinvoq for vitiligo patients aged 12+ as UAE clinics face AED 5,789 monthly drug cost

UAE approves Rinvoq for vitiligo in patients 12+ as first oral systemic option

EDE approved once-daily Rinvoq for eligible non-segmental vitiligo patients. Clinics need prescribing, price and insurance checks.

20 Aug 2026 · 3 min read

UAE approves Rinvoq for vitiligo in patients 12+ as first oral systemic option

UAE approves Rinvoq for vitiligo patients aged 12+, creating first country-level oral licence

Rinvoq is now approved in the UAE for eligible non-segmental vitiligo patients. Clinics and insurers must prepare for systemic therapy demand.

18 Aug 2026 · 3 min read

UAE approves Rinvoq for vitiligo patients aged 12+, creating first country-level oral licence